1. Home
  2. SOBR vs HCWB Comparison

SOBR vs HCWB Comparison

Compare SOBR & HCWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SOBR Safe Inc.

SOBR

SOBR Safe Inc.

HOLD

Current Price

$0.96

Market Cap

3.3M

ML Signal

HOLD

Logo HCW Biologics Inc.

HCWB

HCW Biologics Inc.

HOLD

Current Price

$0.91

Market Cap

3.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOBR
HCWB
Founded
2004
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Newspapers/Magazines
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
3.7M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
SOBR
HCWB
Price
$0.96
$0.91
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$35.00
AVG Volume (30 Days)
158.5K
19.4M
Earning Date
04-14-2026
03-27-2026
Dividend Yield
N/A
N/A
EPS Growth
72.19
N/A
EPS
N/A
N/A
Revenue
$212,736.00
$4,099,750.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
35.25
N/A
52 Week Low
$0.46
$0.22
52 Week High
$7.70
$17.80

Technical Indicators

Market Signals
Indicator
SOBR
HCWB
Relative Strength Index (RSI) 51.98 58.36
Support Level $0.67 $0.49
Resistance Level $2.19 $1.35
Average True Range (ATR) 0.10 0.14
MACD 0.05 0.06
Stochastic Oscillator 70.75 58.77

Price Performance

Historical Comparison
SOBR
HCWB

About SOBR SOBR Safe Inc.

Sobr Safe Inc provides non-invasive technology to quickly and humanely identify the presence of alcohol in individuals. Its technologies are integrated within robust and scalable data platform, producing statistical and measurable user and business data. It developed the scalable, patent-pending ea4 software platform for non-invasive alcohol detection and identity verification, a solution that has current and potential applications. It generates revenue through various combinations of software products and services which include the sale of cloud-based software solutions, detection and data collection hardware devices, and cloud-based data reporting and analysis services.

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

Share on Social Networks: